Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Precipio, Inc. Director's Dealing 2024

Sep 6, 2024

34807_dirs_2024-09-06_33647d03-3c49-4d04-9478-01cfb1bb2931.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Precipio, Inc. (PRPO)
CIK: 0001043961
Period of Report: 2024-08-31

Reporting Person: Gage Matthew (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-31 Stock Option (Right to Buy) $213 D 166 Disposed 2028-02-16 Common Stock (166) Direct
2024-08-31 Stock Option (Right to Buy) $6.56 A 166 Acquired 2028-02-16 Common Stock (166) Direct
2024-08-31 Stock Option (Right to Buy) $45 D 133 Disposed 2029-03-18 Common Stock (133) Direct
2024-08-31 Stock Option (Right to Buy) $6.56 A 133 Acquired 2029-03-18 Common Stock (133) Direct
2024-08-31 Stock Option (Right to Buy) $42.80 D 375 Disposed 2030-01-16 Common Stock (375) Direct
2024-08-31 Stock Option (Right to Buy) $6.56 A 375 Acquired 2030-01-16 Common Stock (375) Direct
2024-08-31 Stock Option (Right to Buy) $44.80 D 400 Disposed 2030-10-20 Common Stock (400) Direct
2024-08-31 Stock Option (Right to Buy) $6.56 A 400 Acquired 2030-10-20 Common Stock (400) Direct
2024-08-31 Stock Option (Right to Buy) $42 D 500 Disposed 2031-01-04 Common Stock (500) Direct
2024-08-31 Stock Option (Right to Buy) $6.56 A 500 Acquired 2031-01-04 Common Stock (500) Direct
2024-08-31 Stock Option (Right to Buy) $64.20 D 1250 Disposed 2031-08-07 Common Stock (1250) Direct
2024-08-31 Stock Option (Right to Buy) $6.56 A 1250 Acquired 2031-08-07 Common Stock (1250) Direct
2024-08-31 Stock Option (Right to Buy) $30.80 D 1000 Disposed 2032-01-11 Common Stock (1000) Direct
2024-08-31 Stock Option (Right to Buy) $6.56 A 1000 Acquired 2032-01-11 Common Stock (1000) Direct

Footnotes

F1: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and become exercisable so that 25% of the options shall vest on the first anniversary of the date of grant and, commencing one month thereafter, the remainder shall vest in 36 equal monthly installments subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

F3: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.